Complete genome sequence of Providencia stuartii clinical isolate MRSN 2154

Journal of Bacteriology

Volumn 194, Issue 14, 2012, Pages 3736-3737

  Clifford, Robert J ^a   Hang, Jun ^a   Riley, Matthew C ^a   Onmus Leone, Fatma ^a   Kuschner, Robert A ^a   Lesho, Emil P ^a   Waterman, Paige E ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIUM ISOLATE; BRAIN; BURN INFECTION; BURN PATIENT; DIARRHEA; ENDOCARDIUM; GENE MAPPING; GENE REARRANGEMENT; GENE SEQUENCE; HUMAN; INDWELLING CATHETER; MENINGITIS; NONHUMAN; NOTE; NUCLEOTIDE SEQUENCE; OPERON; PERITONITIS; PLASMID; PRIORITY JOURNAL; PROVIDENCIA STUARTII; URINARY TRACT INFECTION;

ENTEROBACTERIACEAE INFECTIONS; GENE EXPRESSION REGULATION, BACTERIAL; GENOME, BACTERIAL; HUMANS; MOLECULAR SEQUENCE DATA; PROVIDENCIA;

NEGIBACTERIA; PROVIDENCIA; PROVIDENCIA STUARTII;

EID: 84864019542     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.00615-12     Document Type: Note

References (16)

1. Aubert D, Naas T, Lartigue MF, Nordmann P. 2005. Novel genetic structure associated with an extended-spectrum beta-lactamase blaVEB gene in a Providencia stuartii clinical isolate from Algeria. Antimicrob. Agents Chemother. 49:3590 -3592.
2. Krake PR, Tandon N. 2004. Infective endocarditis due to Providencia stuartii. South. Med. J. 97:1022-1023.
3. McGann P, et al. 2012. Complete sequence of a novel 178-kilobase plasmid carrying blaNDM-1 in a Providencia stuartii strain isolated in Afghanistan. Antimicrob. Agents Chemother. 56:1673-1679.
4. Miriagou V, Tzouvelekis LS, Flevari K, Tsakiri M, Douzinas EE. 2007. Providencia stuartii with VIM-1 metallo-beta-lactamase. J. Antimicrob. Chemother. 60:183-184.
5. Muccio CF, Leonini S, Esposito G, Cerase A. 2011. Pyogenic abscess from Providencia stuartii mimicking necrotic tumour at perfusionweighted imaging. Neurol. Sci. 32:919 -923.
6. O'Hara CM, Brenner FW, Miller JM. 2000. Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clin. Microbiol. Rev. 13:534 -546.
7. Overturf GD, Wilkins J, Ressler R. 1974. Emergence of resistance of Providencia stuartii to multiple antibiotics: speciation and biochemical characterization of Providencia. J. Infect. Dis. 129:353-357.
8. Poirel L, Dortet L, Bernabeu S, Nordmann P. 2011. Genetic features of blaNDM-1-positive Enterobacteriaceae. Antimicrob. Agents Chemother. 55:5403-5407.
9. Quinteros M, et al. 2003. Extended-spectrum beta-lactamases in enterobacteriaceae in Buenos Aires, Argentina, public hospitals. Antimicrob. Agents Chemother. 47:2864 -2867.
10. Sipahi OR, et al. 2010. Meningitis due to Providencia stuartii. J. Clin. Microbiol. 48:4667- 4668.
11. Storey S, McGann PT, Lesho EP, Waterman PE. 2011. Notes from the field: detection of blaNDM-1 carbapenem resistance in a clinical isolate of Providencia stuartii in a U.S./coalition medical facility-Afghanistan, 2011. MMWR Morb. Mortal. Wkly. Rep. 60:756.
12. Tumbarello M, et al. 2004. ESBL-producing multidrug-resistant Providencia stuartii infections in a university hospital. J. Antimicrob. Chemother. 53:277-2782.
13. Unverdi S, et al. 2011. Peritonitis due to Providencia stuartii. Perit. Dial. Int. 31:216 -217.
14. Warren JW. 1986. Providencia stuartii: a common cause of antibioticresistant bacteriuria in patients with long-term indwelling catheters. Rev. Infect. Dis. 8:61- 67.
15. Woods TD, Watanakunakorn C. 1996. Bacteremia due to Providencia stuartii: review of 49 episodes. South. Med. J. 89:221-224.
16. Yoh M, et al. 2005. Importance of Providencia species as a major cause of travelers' diarrhea. J. Med. Microbiol. 54:1077-1082.